These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 9481702)
1. Endothelin receptor antagonists: which are the therapeutic perspectives in renal diseases? Benigni A; Remuzzi G Nephrol Dial Transplant; 1998 Jan; 13(1):5-7. PubMed ID: 9481702 [No Abstract] [Full Text] [Related]
2. Therapeutic potential of endothelin receptor antagonism in kidney disease. Czopek A; Moorhouse R; Webb DJ; Dhaun N Am J Physiol Regul Integr Comp Physiol; 2016 Mar; 310(5):R388-97. PubMed ID: 26702154 [TBL] [Abstract][Full Text] [Related]
3. Endothelin antagonists in renal disease. Hendry BM; James AF Lancet; 1997 Aug; 350(9075):381-2. PubMed ID: 9259650 [No Abstract] [Full Text] [Related]
4. Endothelin in renal pathophysiology: from experimental to therapeutic application. Rabelink TJ; Kaasjager KA; Stroes ES; Koomans HA Kidney Int; 1996 Dec; 50(6):1827-33. PubMed ID: 8943463 [No Abstract] [Full Text] [Related]
5. The renoprotective potential of endothelin receptor antagonists. Knoll T; Schaub M; Birck R; Braun C; Juenemann KP; Rohmeiss P Expert Opin Investig Drugs; 2000 May; 9(5):1041-52. PubMed ID: 11060726 [TBL] [Abstract][Full Text] [Related]
6. Targets for endothelin in the diseased kidney: clues for therapeutic intervention. Rohmeiss P; Birck R; Braun C; Kirchengast M; van der Woude FJ Exp Nephrol; 1999; 7(1):1-10. PubMed ID: 9892807 [TBL] [Abstract][Full Text] [Related]
8. The Twelfth International Conference on Endothelin (ET-12), Cambridge 2011. Barton M; Davenport AP Life Sci; 2012 Oct; 91(13-14):462-5. PubMed ID: 22842028 [TBL] [Abstract][Full Text] [Related]
9. Endothelin in hypertension: a role for receptor antagonists? Moreau P Cardiovasc Res; 1998 Sep; 39(3):534-42. PubMed ID: 9861294 [TBL] [Abstract][Full Text] [Related]
11. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney. Pollock DM; Opgenorth TJ Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752 [TBL] [Abstract][Full Text] [Related]
12. The endothelin system and endothelin receptor antagonists. Jandeleit-Dahm KA; Watson AM Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):66-71. PubMed ID: 22123210 [TBL] [Abstract][Full Text] [Related]
13. Blocking of the endothelin system: the development of receptor antagonists. Battistini B; Dussault P Pulm Pharmacol Ther; 1998; 11(2-3):97-112. PubMed ID: 9918742 [No Abstract] [Full Text] [Related]
15. Endothelin antagonists and resistant hypertension in chronic kidney disease. Moore R; Linas S Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):432-6. PubMed ID: 20502329 [TBL] [Abstract][Full Text] [Related]
16. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney. Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396 [TBL] [Abstract][Full Text] [Related]